Advertisement
Singapore markets closed
  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • Bitcoin USD

    63,949.77
    -990.64 (-1.53%)
     
  • CMC Crypto 200

    1,383.71
    -12.82 (-0.92%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • Dow

    38,239.66
    +153.86 (+0.40%)
     
  • Nasdaq

    15,927.90
    +316.14 (+2.03%)
     
  • Gold

    2,349.60
    +7.10 (+0.30%)
     
  • Crude Oil

    83.66
    +0.09 (+0.11%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     
  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Pot Takes a Hit as Aurora Cannabis Forecasts Weak Quarter

By Christiana Sciaudone

Investing.com -- Pot may be losing its potency. U.S.-listed Aurora Cannabis (NYSE:ACB) tumbled 25% after reporting weak sales guidance.

Cannabis net revenue for the first quarter of 2021 is expected to be between C$60 million and C$64 million, compared to C$67.56 million in the fourth quarter. In the fourth quarter a year earlier, Aurora reported cannabis net revenue of C$94.6 million.

The company expects adjusted gross margin before fair value adjustments on cannabis net revenue to be within a range of 46% to 50% and SG&A costs in the low C$40 million range.

Aurora reported a 4.5% quarter-on-quarter decline in fourth quarter net revenue to C$72.11 million.

ADVERTISEMENT

Shares are down 79% in 2020.

Rivals also fell on the news, with Canopy Growth (NYSE:CGC) down 10%, Aphria (NASDAQ:APHA) lower by 3% and Cronos decreasing by almost 6%.

Related Articles

TikTok asks judge to block U.S. from barring app for download

Disney delays 'Black Widow' in new setback for cinemas

Hasbro Up on BMO Boost as Parents Stuck at Home with Kids